0938-AT97 202004 Unified Agenda of Federal Regulatory and Deregulatory Actions 0938 Centers for Medicare & Medicaid Services CMS 0900 Department of Health and Human Services HHS Contract Year 2021 Policy and Technical Changes to the Medicare Advantage, Medicare Prescription Drug Benefit, Medicaid, and Medicare Cost Plans (CMS-4190)

This final rule will revise regulations for the Medicare Advantage (MA or Part C) program, Medicare Prescription Drug Benefit (Part D) program, and Medicare Cost Plan program to implement certain sections of the Bipartisan Budget Act of 2018 and the 21st Century Cures Act. In addition, it will enhance the Part C and D programs, codify several existing CMS policies, and implement other technical changes. This final rule implements a subset of the proposals from the February 18, 2020, proposed rule (85 FR 9002). CMS intends to address the remaining proposals from the February 2020 proposed rule in subsequent rulemaking.

]]> Economically Significant Previously Published in The Unified Agenda Final Rule Stage Yes No Deregulatory 42 CFR 405 42 CFR 417 42 CFR 422 42 CFR 423 ... 42 U.S.C. 1302 42 U.S.C. 1395hh Pub. L. 115-271 Statutory Final 01/01/2021 SUPPORT for Patients and Communities Act Rule includes provisions of the "Support for Patients and Communities Act" required to be implemented by 01/01/2021. Yes NPRM 02/18/2020 85 FR 9002 NPRM Comment Period End 04/06/2020 Final Action 01/00/2021 No None No No No Heather Barkes Director, Division of Policy, Analysis, and Planning 0938 Centers for Medicare & Medicaid Services CMS 410 786-8615 heather.barkes@cms.hhs.gov Center for Medicare, MS: C4-21-26, 7500 Security Boulevard, Baltimore MD 21244